These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2871050

  • 1. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.
    Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB.
    J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050
    [Abstract] [Full Text] [Related]

  • 2. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D.
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [Abstract] [Full Text] [Related]

  • 3. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Apr; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 4. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL.
    Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 6. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC, Swinson RP.
    Psychopharmacol Bull; 1986 Feb; 22(1):173-6. PubMed ID: 3726063
    [No Abstract] [Full Text] [Related]

  • 7. The relationship of alprazolam dose to steady-state plasma concentrations.
    Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.
    J Clin Psychopharmacol; 1990 Feb; 10(1):27-32. PubMed ID: 2407754
    [Abstract] [Full Text] [Related]

  • 8. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Feb; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 9. Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.
    Greenblatt DJ, Harmatz JS, Shader RI.
    Arch Gen Psychiatry; 1993 Sep; 50(9):715-22. PubMed ID: 8357297
    [Abstract] [Full Text] [Related]

  • 10. Alprazolam in the treatment of panic disorders.
    Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SR, Goetz D, Klein DF.
    J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
    [Abstract] [Full Text] [Related]

  • 11. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepines in panic disorder and agoraphobia.
    Sheehan DV.
    J Affect Disord; 1987 Feb; 13(2):169-81. PubMed ID: 2890678
    [Abstract] [Full Text] [Related]

  • 13. Alprazolam treatment for panic disorders.
    Alexander PE, Alexander DD.
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [Abstract] [Full Text] [Related]

  • 14. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [Abstract] [Full Text] [Related]

  • 15. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA, Tesar GE, Rosenbaum JF, Woods SW.
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [Abstract] [Full Text] [Related]

  • 16. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV.
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [Abstract] [Full Text] [Related]

  • 17. Clinical pharmacokinetics of alprazolam. Therapeutic implications.
    Greenblatt DJ, Wright CE.
    Clin Pharmacokinet; 1993 Jun; 24(6):453-71. PubMed ID: 8513649
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapeutic considerations in anxiety disorders.
    Hollister LE.
    J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of tricyclic antidepressants in panic disorder.
    Sweeney DR, Gold MS, Pottash AL, Martin D.
    Int J Psychiatry Med; 1986 Jun; 13(2):93-6. PubMed ID: 6642878
    [Abstract] [Full Text] [Related]

  • 20. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W, Noyes R.
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.